Cardiac arrest associated with hypokalaemia in a patient receiving mithramycin.
作者信息
Bashir Y, Tomson C R
机构信息
Department of Neurology, General Hospital, Newcastle on Tyne, UK.
出版信息
Postgrad Med J. 1988 Mar;64(749):228-9. doi: 10.1136/pgmj.64.749.228.
Abstract
The case is reported of a patient who developed severe hypokalaemia, leading to cardiac arrest, while receiving mithramycin for painful Paget's disease. The patient was also receiving antihypertensive and anti-anginal treatment including bendrofluazide, but plasma potassium before the administration of mithramycin was normal. Hypokalaemia has been reported in previous studies of the use of mithramycin but has received little attention. The drug should be used with great care in patients with cardiovascular disease and in those receiving diuretics.
摘要
相似文献
1
Cardiac arrest associated with hypokalaemia in a patient receiving mithramycin.
Postgrad Med J. 1988 Mar;64(749):228-9. doi: 10.1136/pgmj.64.749.228.
2
Treatment of Paget's disease of bone with mithramycin.
Clin Orthop Relat Res. 1977(127):106-10.
3
Mithramycin in Paget's disease of bone.
Lancet. 1973 Jun 9;1(7815):1319. doi: 10.1016/s0140-6736(73)91334-2.
4
The role of mithramycin in the management of Paget's disease.
Metab Bone Dis Relat Res. 1981;3(4-5):343-5. doi: 10.1016/0221-8747(81)90051-5.
5
Mithramycin in the treatment of Paget's disease of bone.
J Bone Joint Surg Am. 1972 Dec;54(8):1730-6.
6
Mithramycin in Paget's disease.
S Afr Med J. 1974 Jun 9;48(31):1328-30.
7
[Clinical and metabolic effects of mithramycin and glucagon in the treatment of Paget's disease].
Union Med Can. 1978 Sep;107(9):849-56.
8
Outpatient treatment of Paget's disease of bone with mithramycin.
Ann Intern Med. 1974 Nov;81(5):635-7. doi: 10.7326/0003-4819-81-5-635.
9
Treatment of Paget's disease with mithramycin: further experiences.
Semin Drug Treat. 1972 Summer;2(1):57-64.
10
Mithramycin in Paget's disease.
Lancet. 1978 Jun 10;1(8076):1267. doi: 10.1016/s0140-6736(78)92510-2.
本文引用的文献
1
The role of mithramycin in the management of Paget's disease.
Metab Bone Dis Relat Res. 1981;3(4-5):343-5. doi: 10.1016/0221-8747(81)90051-5.
2
Acute transient hypokalaemia: new interpretation of a common event.
Lancet. 1982 Oct 2;2(8301):751-2. doi: 10.1016/s0140-6736(82)90930-8.
3
Effects of mithramycin on Paget's disease of bone.
Ann Intern Med. 1969 Mar;70(3):549-57. doi: 10.7326/0003-4819-70-3-549.
4
Experiences in the treatment of Paget's disease of bone with mithramycin.
JAMA. 1970 Aug 17;213(7):1153-7.
5
Renal function and alterations in plasma electrolyte levels in normocalcaemic and hypercalaemic patients with malignant diseases, given an intravenous infusion of mithramycin.
Chemotherapy. 1974;20(5):280-95. doi: 10.1159/000221817.
6
Mithramycin in the treatment of Paget's disease of bone.
J Bone Joint Surg Am. 1972 Dec;54(8):1730-6.
Zotero 插件